Jeff Tyner, Ph.D. (2018)
Jeff Tyner, Ph.D., associate professor in the OHSU School of Medicine department of Cell, Developmental & Cancer Biology and researcher with the OHSU Knight Cancer Institute, Sept. 12, 2018. (OHSU/Kristyna Wentz-Graff)
Steven Mansoor, M.D., Ph.D.
Steven Mansoor, M.D., Ph.D., and colleagues have identified the inner workings of the P2X7 protein receptor, which is associated with inflammation, coronary artery disease, cancer, multiple sclerosis and more. (OHSU)
OHSU Match Day 2024: A career-defining moment for soon-to-be physicians
Match Day de OHSU 2024: un momento decisivo para la carrera de los futuros médicos
OHSU Knight Cancer Institute Leadership Announcement
Brian Druker, M.D., and Tom Sellers, Ph.D., M.P.H. (OHSU)
Video download: Meet Dr. Tom Sellers
Tom Sellers, M.D., M.P.H., newly announced director of the OHSU Knight Cancer Institute, introduces himself to the members of the institute. (OHSU).
OHSU Knight Cancer Institute announces leadership transition
Research sheds light on new strategy to treat infertility
Cellular therapy program
Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program at the OHSU Knight Cancer Institute. Researchers in the program are looking for new ways to treat lethal cancers such as skin cancer. (OHSU/Kristyna Wentz-Graff)